Chart/Volume Play – be sure that you read Curis’s PR beforehands: Curis, Inc. (CRIS), a biotechnology company, announced on September 14th, 2014 the pricing of an underwritten public offering of 20,000,000 shares of its common stock (the “Offering”). The Offering is expected to close on or about September 18, 2017, subject to customary closing conditions. […]